James M Hartford, MD
Orthopedic Surgery · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 057003 · 057004 · 057007 · 058123 · 757662 · Mills-Peninsula Medical Center · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hartford’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G81676 · Current
Licensed to practise in California · since 1995 · expires 2028-10-31 · Dartmouth Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$395,700
Medicare paid this office $395,700 for 751 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of thigh bone and hip joint with prosthesis | 111 | $137,292 | $1,154 |
| Replacement of knee joint, both sides of knee | 77 | $90,046 | $1,140 |
| Short return visit (20+ min) | 350 | $34,948 | $82 |
| Long return visit (40+ min) | 184 | $29,678 | $155 |
| Return visit (30+ min) | 191 | $24,830 | $118 |
See all 15 services
| Replacement of thigh bone and hip joint with prosthesis | 111 | $137,292 | $1,154 |
| Replacement of knee joint, both sides of knee | 77 | $90,046 | $1,140 |
| Short return visit (20+ min) | 350 | $34,948 | $82 |
| Long return visit (40+ min) | 184 | $29,678 | $155 |
| Return visit (30+ min) | 191 | $24,830 | $118 |
| New patient visit (60+ min) | 67 | $12,850 | $192 |
| New patient visit (45+ min) | 74 | $10,216 | $138 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 92 | $8,483 | $86 |
| Aspiration and/or injection of fluid from large joint | 97 | $7,597 | $67 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 33 | $6,024 | $177 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 21 | $3,290 | None |
| Short return visit | 41 | $2,876 | $54 |
| New patient visit (30+ min) | 22 | $2,045 | $93 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 54 | $841 | $15 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 37 | $236 | None |
Procedures Medicare counted
| Hip replacement | 126 | More than 99% of doctors who do this |
| Knee replacement | 112 | More than 94% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
751 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 5% · Health risk score 0.86. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 66% · Coronary heart disease 23% · Diabetes 20% · Chronic kidney disease 17% · Atrial fibrillation 16% · Depression 16% · Cancer 14% · Heart failure 10% · COPD 7% · Stroke 4% · Dementia 2%.
The office billed $1,976,053, Medicare allowed $508,635 and paid $395,700; for 2,211 services of 42 kinds; $4,069 of it was for drugs given in the office and $391,630 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 751 | 2,211 | 76 | 0.86 | $1,976,053 | $395,700 |
| 2023 | 677 | 1,558 | 76 | 0.80 | $1,766,556 | $366,676 |
| 2022 | 714 | 1,674 | 76 | 0.81 | $1,616,498 | $358,020 |
| 2021 | 735 | 1,639 | 76 | 0.86 | $1,596,458 | $355,760 |
| 2020 | 645 | 1,372 | 75 | 0.89 | $1,354,877 | $303,683 |
| 2019 | 726 | 1,537 | 75 | 0.83 | $1,885,313 | $412,330 |
| 2018 | 684 | 1,436 | 74 | 0.92 | $1,557,817 | $338,049 |
| 2017 | 643 | 1,249 | 75 | 0.98 | $1,230,916 | $274,504 |
| 2016 | 662 | 1,525 | 75 | 1.01 | $1,451,600 | $332,566 |
| 2015 | 698 | 1,567 | 75 | 0.98 | $1,492,576 | $358,585 |
| 2014 | 682 | 1,623 | 75 | 0.96 | $1,375,308 | $313,475 |
| 2013 | 613 | 1,518 | 74 | 0.94 | $1,251,602 | $305,467 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Replacement of knee joint, both sides of knee | 103 | $129,222 | $1,175 |
| Replacement of thigh bone and hip joint with prosthesis | 84 | $100,216 | $1,179 |
| Short return visit (20+ min) | 329 | $31,867 | $82 |
| Long return visit (40+ min) | 170 | $26,721 | $154 |
| Return visit (30+ min) | 166 | $21,283 | $116 |
| New patient visit (60+ min) | 53 | $10,245 | $193 |
| New patient visit (45+ min) | 70 | $9,784 | $140 |
| Aspiration and/or injection of fluid from large joint | 72 | $5,896 | $68 |
| Short return visit | 45 | $2,606 | $53 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 13 | $2,076 | None |
| New patient visit (30+ min) | 24 | $1,781 | $74 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 17 | $1,482 | $87 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $516 | $21 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 38 | $328 | None |
2022: 13 services
| Replacement of knee joint, both sides of knee | 89 | $107,440 | $1,168 |
| Replacement of thigh bone and hip joint with prosthesis | 83 | $101,347 | $1,165 |
| Short return visit (20+ min) | 297 | $28,841 | $80 |
| Long return visit (40+ min) | 164 | $28,198 | $167 |
| Return visit (30+ min) | 199 | $24,660 | $114 |
| New patient visit (45+ min) | 83 | $11,618 | $140 |
| New patient visit (60+ min) | 49 | $9,781 | $200 |
| Aspiration and/or injection of fluid from large joint | 96 | $8,297 | $66 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 32 | $7,592 | None |
| New patient visit (30+ min) | 34 | $3,256 | $96 |
| Short return visit | 43 | $2,531 | $53 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $623 | $24 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 56 | $538 | None |
2021: 13 services
| Replacement of thigh bone and hip joint with prosthesis | 92 | $112,202 | $1,181 |
| Replacement of knee joint, both sides of knee | 76 | $91,726 | $1,176 |
| Short return visit (20+ min) | 364 | $36,441 | $82 |
| Return visit (30+ min) | 226 | $29,467 | $120 |
| Aspiration and/or injection of fluid from large joint | 124 | $11,100 | $69 |
| New patient visit (30+ min) | 110 | $11,096 | $101 |
| New patient visit (45+ min) | 67 | $10,052 | $150 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 47 | $8,985 | None |
| Long return visit (40+ min) | 44 | $7,130 | $155 |
| Short return visit | 76 | $4,693 | $53 |
| New patient visit (60+ min) | 14 | $2,870 | $205 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 76 | $777 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $438 | $23 |
2020: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 81 | $103,043 | $1,241 |
| Replacement of knee joint, both sides of knee | 63 | $81,252 | $1,250 |
| Short return visit (20+ min) | 349 | $28,108 | $66 |
| Return visit (30+ min) | 170 | $17,416 | $97 |
| Aspiration and/or injection of fluid from large joint | 106 | $8,876 | $66 |
| New patient visit (45+ min) | 56 | $8,478 | $151 |
| New patient visit (30+ min) | 89 | $8,426 | $95 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 32 | $6,889 | None |
| Short return visit | 85 | $3,796 | $42 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $741 | $67 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 68 | $596 | None |
2019: 10 services
| Replacement of thigh bone and hip joint with prosthesis | 117 | $145,435 | $1,222 |
| Replacement of knee joint, both sides of knee | 103 | $131,805 | $1,220 |
| Short return visit (20+ min) | 380 | $30,355 | $65 |
| Return visit (30+ min) | 187 | $18,953 | $96 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 49 | $14,774 | None |
| New patient visit (45+ min) | 75 | $10,589 | $141 |
| New patient visit (30+ min) | 95 | $8,777 | $92 |
| Aspiration and/or injection of fluid from large joint | 99 | $7,462 | $62 |
| Short return visit | 124 | $5,466 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 44 | $448 | None |
2018: 10 services
| Replacement of thigh bone and hip joint with prosthesis | 92 | $116,316 | $1,224 |
| Replacement of knee joint, both sides of knee | 82 | $102,629 | $1,207 |
| Short return visit (20+ min) | 339 | $25,589 | $61 |
| Return visit (30+ min) | 194 | $18,246 | $89 |
| New patient visit (45+ min) | 75 | $10,190 | $136 |
| New patient visit (30+ min) | 88 | $7,846 | $89 |
| Aspiration and/or injection of fluid from large joint | 99 | $7,120 | $56 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 41 | $6,546 | None |
| Short return visit | 103 | $4,599 | $40 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 52 | $540 | None |
2017: 11 services
| Replacement of knee joint, both sides of knee | 81 | $101,701 | $1,225 |
| Replacement of thigh bone and hip joint with prosthesis | 66 | $79,351 | $1,202 |
| Short return visit (20+ min) | 333 | $24,015 | $60 |
| Return visit (30+ min) | 142 | $13,763 | $91 |
| New patient visit (45+ min) | 67 | $9,390 | $140 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 36 | $8,292 | None |
| Aspiration and/or injection of fluid from large joint | 81 | $6,956 | $60 |
| New patient visit (30+ min) | 78 | $6,772 | $87 |
| Short return visit | 91 | $3,389 | $34 |
| Long return visit (40+ min) | 15 | $2,029 | $135 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 42 | $299 | None |
2016: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 93 | $113,088 | $1,190 |
| Replacement of knee joint, both sides of knee | 78 | $97,920 | $1,239 |
| Short return visit (20+ min) | 362 | $29,431 | $62 |
| Return visit (30+ min) | 187 | $17,646 | $91 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 53 | $15,866 | None |
| Aspiration and/or injection of fluid from large joint | 106 | $10,492 | $61 |
| New patient visit (30+ min) | 89 | $7,575 | $85 |
| New patient visit (45+ min) | 51 | $7,199 | $141 |
| Short return visit | 93 | $4,086 | $39 |
| Long return visit (40+ min) | 14 | $1,503 | $107 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 51 | $359 | None |
2015: 9 services
| Replacement of thigh bone and hip joint with prosthesis | 95 | $127,389 | $1,300 |
| Replacement of knee joint, both sides of knee | 72 | $94,767 | $1,281 |
| Short return visit (20+ min) | 418 | $36,698 | $68 |
| New patient visit (30+ min) | 178 | $17,380 | $98 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 52 | $12,571 | None |
| Aspiration and/or injection of fluid from large joint | 131 | $11,002 | $64 |
| Return visit (30+ min) | 106 | $10,740 | $99 |
| Short return visit | 107 | $4,985 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 81 | $506 | None |
2014: 9 services
| Replacement of thigh bone and hip joint with prosthesis | 72 | $93,035 | $1,224 |
| Replacement of knee joint, both sides of knee | 67 | $88,096 | $1,259 |
| Short return visit (20+ min) | 395 | $32,242 | $62 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 58 | $16,899 | None |
| New patient visit (30+ min) | 176 | $16,452 | $93 |
| Aspiration and/or injection of fluid from large joint | 145 | $13,252 | $58 |
| Return visit (30+ min) | 124 | $12,029 | $93 |
| Short return visit | 95 | $3,831 | $36 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 79 | $505 | None |
2013: 9 services
| Replacement of thigh bone and hip joint with prosthesis | 80 | $105,784 | $1,290 |
| Replacement of knee joint, both sides of knee | 47 | $67,493 | $1,377 |
| Short return visit (20+ min) | 366 | $31,184 | $64 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 51 | $15,886 | None |
| New patient visit (30+ min) | 152 | $13,359 | $88 |
| Aspiration and/or injection of fluid from large joint | 115 | $10,847 | $50 |
| Return visit (30+ min) | 107 | $10,545 | $95 |
| Short return visit | 109 | $5,188 | $40 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 62 | $346 | None |
Drugs they prescribed that Part D paid
$2,507
Pharmacies billed $2,507 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
289 generic and fewer than 11 brand-name prescriptions · $2,507 in drug cost · 218 antibiotic prescriptions to 194 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin | 157 | $585 | $3 |
| Meloxicam | 14 | $159 | $7 |
| Clindamycin | 27 | $133 | $5 |
Year by year
| 2024 | 290 | 228 | None | None | $2,507 |
| 2023 | 262 | 214 | None | None | $1,987 |
| 2022 | 289 | 208 | 5% (15) | None | $4,626 |
| 2021 | 248 | 190 | 6% (15) | None | $4,312 |
| 2020 | 255 | 173 | 6% (14) | 4% | $7,792 |
| 2019 | 325 | 207 | 11% (34) | 4% | $5,150 |
| 2018 | 275 | 168 | 9% (25) | 4% | $6,014 |
| 2017 | 391 | 208 | 19% (73) | 5% | $10,005 |
| 2016 | 417 | 227 | 13% (55) | 17% | $19,906 |
| 2015 | 516 | 226 | 26% (136) | 24% | $29,136 |
| 2014 | 445 | 202 | 40% (178) | 18% | $22,195 |
| 2013 | 440 | 172 | 41% (179) | 20% | $26,080 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Amoxicillin | 139 | $476 | $3 |
| Clindamycin | 37 | $195 | $5 |
| Meloxicam | 23 | $131 | $6 |
2022: 5 drugs
| Celecoxib | 33 | $1,485 | $45 |
| Amoxicillin | 137 | $454 | $3 |
| Diclofenac | 11 | $437 | $40 |
| Clindamycin | 30 | $138 | $5 |
| Meloxicam | 16 | $44 | $3 |
2021: 4 drugs
| Diclofenac | 16 | $484 | $30 |
| Amoxicillin | 107 | $342 | $3 |
| Meloxicam | 34 | $213 | $6 |
| Clindamycin | 28 | $145 | $5 |
2020: 5 drugs
| Diclofenac | 31 | $1,298 | $42 |
| Celecoxib | 24 | $1,156 | $48 |
| Amoxicillin | 93 | $317 | $3 |
| Meloxicam | 26 | $159 | $6 |
| Clindamycin | 23 | $113 | $5 |
2019: 7 drugs
| Celecoxib | 32 | $1,178 | $37 |
| Diclofenac | 19 | $844 | $44 |
| Enoxaparin | 12 | $606 | $50 |
| Amoxicillin | 94 | $384 | $4 |
| Meloxicam | 46 | $276 | $6 |
| Clindamycin | 34 | $170 | $5 |
| Tramadol | 15 | $72 | $5 |
2018: 7 drugs
| Celecoxib | 31 | $2,183 | $70 |
| Diclofenac | 17 | $1,156 | $68 |
| Enoxaparin | 11 | $629 | $57 |
| Amoxicillin | 73 | $313 | $4 |
| Meloxicam | 32 | $231 | $7 |
| Gabapentin | 11 | $114 | $10 |
| Clindamycin | 17 | $76 | $4 |
2017: 12 drugs
| Celecoxib | 58 | $4,631 | $80 |
| Enoxaparin | 15 | $943 | $63 |
| Diclofenac | 12 | $467 | $39 |
| Amoxicillin | 79 | $274 | $3 |
| Oxycodone | 15 | $219 | $15 |
| Meloxicam | 35 | $168 | $5 |
| Pantoprazole | 27 | $163 | $6 |
| Clindamycin | 31 | $149 | $5 |
| Gabapentin | 12 | $124 | $10 |
| Oxycodone-Acetaminophen | 11 | $108 | $10 |
| Tramadol | 21 | $87 | $4 |
| Hydrocodone-Acetaminophen | 12 | $81 | $7 |
2016: 9 drugs
| Celecoxib | 86 | $8,026 | $93 |
| Enoxaparin | 33 | $5,276 | $160 |
| Voltaren | 11 | $590 | $54 |
| Amoxicillin | 80 | $351 | $4 |
| Oxycodone | 12 | $215 | $18 |
| Meloxicam | 47 | $214 | $5 |
| Clindamycin | 25 | $120 | $5 |
| Tramadol | 14 | $69 | $5 |
| Pantoprazole | 11 | $58 | $5 |
2015: 14 drugs
| Celecoxib | 108 | $12,347 | $114 |
| Enoxaparin | 34 | $5,321 | $157 |
| Oxycontin | 20 | $2,936 | $147 |
| Temazepam | 25 | $1,731 | $69 |
| Oxycodone | 53 | $1,023 | $19 |
| Voltaren | 18 | $1,017 | $56 |
| Oxycodone-Acetaminophen | 13 | $489 | $38 |
| Nabumetone | 17 | $360 | $21 |
| Hydrocodone-Acetaminophen | 16 | $324 | $20 |
| Meloxicam | 38 | $222 | $6 |
| Amoxicillin | 50 | $219 | $4 |
| Tramadol | 28 | $128 | $5 |
| Clindamycin | 15 | $52 | $3 |
| Zolpidem | 11 | $51 | $5 |
2014: 13 drugs
| Celebrex | 27 | $7,317 | $271 |
| Enoxaparin | 19 | $4,140 | $218 |
| Oxycontin | 12 | $1,230 | $103 |
| Hydrocodone-Acetaminophen | 33 | $946 | $29 |
| Oxycodone | 48 | $920 | $19 |
| Voltaren | 15 | $825 | $55 |
| Oxycodone-Acetaminophen | 38 | $765 | $20 |
| Nabumetone | 20 | $517 | $26 |
| Amoxicillin | 50 | $237 | $5 |
| Meloxicam | 26 | $179 | $7 |
| Tramadol | 28 | $144 | $5 |
| Clindamycin | 16 | $83 | $5 |
| Zolpidem | 12 | $52 | $4 |
2013: 13 drugs
| Enoxaparin | 37 | $11,607 | $314 |
| Celebrex | 25 | $6,259 | $250 |
| Oxycontin | 24 | $1,977 | $82 |
| Oxycodone-Acetaminophen | 48 | $662 | $14 |
| Nabumetone | 21 | $379 | $18 |
| Hydrocodone-Acetaminophen | 42 | $337 | $8 |
| Roxicet | 27 | $275 | $10 |
| Amoxicillin | 47 | $254 | $5 |
| Meloxicam | 26 | $226 | $9 |
| Hydromorphone | 15 | $151 | $10 |
| Pantoprazole | 12 | $106 | $9 |
| Clindamycin | 13 | $89 | $7 |
| Prochlorperazine Maleate | 17 | $88 | $5 |
Money from drug and device companies
$788 in 2025
| 2025 | 4 | 11 | None | $788 |
| 2024 | 2 | 2 | None | $183 |
| 2023 | 2 | 4 | None | $554 |
| 2022 | 2 | 5 | None | $1,036 |
| 2021 | 4 | 19 | None | $1,955 |
| 2020 | 1 | 2 | None | $143 |
| 2019 | 5 | 6 | None | $577 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $462 | 7 payments
|
| Davol | Channel Drain | $152 | 1 payment
|
| Medtronic | Aquamantys(Tm) | $95 | 2 payments
|
| DePuy Synthes Sales | None | $79 | 1 payment
|
See all 11 published payments
| Medtronic | Meals · 2025-12-08 | Aquamantys(Tm) | $21 |
| Stryker | Meals · 2025-10-30 | Tbcem | $17 |
| Stryker | Travel · 2025-10-25 | Mako | $44 |
| Stryker | Meals · 2025-10-24 | Mako | $173 |
| Stryker | Meals · 2025-10-13 | Exeter | $70 |
| Stryker | Meals · 2025-10-13 | Exeter | $55 |
| Stryker | Meals · 2025-09-23 | Tbcem | $19 |
| Davol | Meals · 2025-09-17 | Channel Drain | $152 |
| Medtronic | Meals · 2025-09-05 | Aquamantys(Tm) | $73 |
| Stryker | Meals · 2025-07-12 | Mako | $83 |
| DePuy Synthes Sales | Meals · 2025-03-13 | None | $79 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $183
| DePuy Synthes Sales | None | $103 | 1 payment
|
| Heron Therapeutics | Zynrelef | $80 | 1 payment
|
2023: $554
| Zimmer Biomet Holdings | Avenir | $478 | 3 payments
|
| Stryker | Mako | $77 | 1 payment
|
2022: $1,036
| Stryker | Mako | $814 | 3 payments
|
| Zimmer Biomet Holdings | Rosa | $222 | 2 payments
|
2021: $1,955
| Stryker | Mako | $1,115 | 12 payments
|
| DePuy Synthes Sales | Velys | $643 | 3 payments
|
| Zimmer Biomet Holdings | Rosa-Knee | $158 | 2 payments
|
| Medical Device Business Services | Attune | $39 | 2 payments
|
2020: $143
| Medtronic USA | Aquamantys | $143 | 2 payments
|
2019: $577
| Zimmer Biomet Holdings | Connected Health Product Portfolio | $257 | 2 payments
|
| Kci USA | Prevena | $109 | 1 payment
|
| DePuy Synthes Sales | None | $105 | 1 payment
|
| Avanos Medical | None | $56 | 1 payment
|
| Orthalign | Orthalign Plus System | $50 | 1 payment
|
Professional record
- NPI
- 1922162502
- Licence
- CA G81676California G81676: Current · expires 2028-10-31
- Trained
- Geisel School of Medicine at Dartmouth, 1989
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-12-20
- NPI last updated
- 2012-01-10
This is when the NPI record was last certified, not a medical board exam.